A Randomized-Controlled Trial to Increase the Uptake of LARCs in Cameroon

NACompletedINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2024

Conditions
ContraceptionContraception BehaviorContraceptive UsageContraceptive Method Switching
Interventions
BEHAVIORAL

Price discounts for SARCs

SARCs are offered free to the client

BEHAVIORAL

Price discounts for LARCs

LARCs are offered at lower prices to the client

BEHAVIORAL

Sequential vs. simultaneous recommendations

Top ranked methods are presented to the client sequentially or simultaneously

Trial Locations (1)

Unknown

Hôpital gynéco-obstétrique et pédiatrique de Yaoundé (HGOPY), Yaoundé

All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

George Washington University

OTHER

collaborator

University of Exeter

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Yaounde Gynecology, Obstetrics and Pediatrics Hospital

UNKNOWN

lead

World Bank

OTHER

NCT03733678 - A Randomized-Controlled Trial to Increase the Uptake of LARCs in Cameroon | Biotech Hunter | Biotech Hunter